MiR‐155 promotes interleukin‐1β‐induced chondrocyte apoptosis and catabolic activity by targeting PIK3R1‐mediated PI3K/Akt pathway

Zhiyong Fan, Yinghui Liu, Zhengliang Shi, Kai Deng, Hua Zhang, Qiutong Li, Shuxing Cao, Shentai Li, Hongliang ZhangJournal of Cellular and Molecular Medicine 2020 · DOI

TL;DR

This study reveals that microRNA-155 (miR-155) plays a detrimental role in osteoarthritis (OA) by promoting the death and destructive activity of chondrocytes. It achieves this by targeting PIK3R1, a key component of the PI3K/Akt signaling pathway, which is crucial for chondrocyte survival and function. This discovery offers a potential new therapeutic target for mitigating OA progression.

What Problem Does This Paper Address?

Osteoarthritis (OA) is a debilitating joint disease characterized by the progressive breakdown of articular cartilage. This degradation is driven by two main processes: chondrocyte apoptosis (programmed cell death) and increased catabolic activity (the breakdown of cartilage components). While these processes are known to be central to OA pathogenesis, the precise molecular mechanisms that regulate them, particularly those involving non-coding RNAs like microRNAs (miRNAs), remain incompletely understood. This knowledge gap hinders the development of effective treatments that can actually modify the disease's progression. This paper aims to explore the role of miR-155, a miRNA known to be involved in other pathological conditions, in the context of OA, specifically its influence on chondrocyte apoptosis and catabolic activity.

Methods

The researchers employed a multi-pronged approach to investigate the role of miR-155 in OA:

  • Human Tissue Analysis: They analyzed cartilage biopsies from both OA patients and healthy controls to assess miR-155 levels and markers of cartilage degradation (cleaved caspase-3, collagen II, aggrecan, MMP3, MMP13).
  • In Vitro Chondrocyte Culture: Primary human chondrocytes were isolated and cultured. These cells were then treated with interleukin-1β (IL-1β), a pro-inflammatory cytokine known to induce OA-like changes, to mimic the pathological environment.
  • MiRNA Manipulation: They used synthetic miR-155 inhibitors to reduce miR-155 levels and miR-155 mimics to overexpress it in chondrocytes.
  • Gene Silencing and Overexpression: Short interfering RNAs (siRNAs) were used to knock down the expression of PIK3R1, and pcDNA vectors were used to overexpress it.
  • Molecular Assays:
    • Quantitative Real-Time PCR (qRT-PCR): Used to measure the expression levels of miR-155 and PIK3R1 mRNA.
  • Western Blot Analysis: Employed to detect and quantify the protein levels of various markers, including cleaved caspase-3, collagen II, aggrecan, MMP3, MMP13, PIK3R1, phosphorylated Akt (p-Akt), and total Akt.
  • TUNEL Assay: A standard method for detecting apoptotic cells.
  • Luciferase Reporter Assay: Used to confirm the direct binding of miR-155 to the 3'-UTR of PIK3R1 mRNA.
  • Signaling Pathway Inhibition: A specific Akt inhibitor (MK-2206) was used to block the PI3K/Akt pathway.

Datasets

Not discussed in the paper. The study primarily utilized primary human chondrocytes and cartilage tissues obtained from patients.

Key Insights and Ideas

  • miR-155 is a key player in OA pathology: The study strongly implicates miR-155 as a driver of OA progression, not just a bystander. Its elevated levels in OA cartilage and its ability to exacerbate IL-1β-induced damage are significant findings.
  • Direct targeting of PIK3R1: The identification of PIK3R1 as a direct target of miR-155 is crucial. This provides a concrete molecular link between the miRNA and a critical signaling pathway.
  • PI3K/Akt pathway as the downstream mediator: The research clearly demonstrates that miR-155 exerts its effects by modulating the PI3K/Akt pathway via PIK3R1. This pathway is known to be important for cell survival and function, making its dysregulation a significant factor in OA.
  • Therapeutic potential of targeting miR-155/PIK3R1 axis: The findings suggest that inhibiting miR-155 or restoring PIK3R1 levels could be promising strategies for treating OA.

Key Results

  • Elevated miR-155 in OA: miR-155 levels were significantly higher in OA cartilage tissues compared to normal controls and positively correlated with OA severity (as graded by the Mankin scale).
  • IL-1β induces miR-155: Treatment of primary chondrocytes with IL-1β dose-dependently increased miR-155 expression.
  • miR-155 promotes apoptosis and catabolism:
    • Inhibition of miR-155 attenuated IL-1β-induced chondrocyte apoptosis and catabolic activity (decreased cleaved caspase-3, MMP3, MMP13; increased collagen II, aggrecan).
  • Overexpression of miR-155 exacerbated these effects.
  • PIK3R1 is a direct target of miR-155: Luciferase reporter assays confirmed that miR-155 directly binds to the 3'-UTR of PIK3R1. Inhibition of miR-155 increased PIK3R1 expression, while overexpression decreased it.
  • PIK3R1 restoration rescues miR-155 effects: Knocking down PIK3R1 reversed the protective effects of miR-155 inhibition. Conversely, restoring PIK3R1 expression reversed the detrimental effects of miR-155 overexpression.
  • PI3K/Akt pathway involvement: miR-155 inhibition led to increased PIK3R1 and p-Akt levels, while miR-155 overexpression decreased them. Inhibition of Akt with MK-2206 mimicked the effects of PIK3R1 knockdown, reversing miR-155's pro-apoptotic and catabolic actions.

Limitations and Future Work

  • In vitro focus: The study was primarily conducted using in vitro assays with cultured chondrocytes. The authors acknowledge that in vivo studies using OA animal models are warranted to confirm these findings and establish a more direct physiological connection between miR-155 and OA pathology.
  • Mechanism of IL-1β-induced miR-155 upregulation: While the study shows IL-1β induces miR-155, the precise molecular mechanism behind this upregulation in chondrocytes requires further investigation.
  • PIK3R1's role in OA pathogenesis: The study identified PIK3R1 as a target, but PIK3R1 gene loci have also been associated with hip OA, suggesting PIK3R1 itself may have broader roles in OA pathogenesis beyond its interaction with miR-155. Further research could explore these independent roles.
  • Diagnostic potential of miR-155: The observed correlation between miR-155 levels and OA severity suggests potential diagnostic value, which could be explored in larger clinical studies.

Summary updated

Abstract

Osteoarthritis (OA) is a common joint disease characterized by progressive cartilage degradation, in which elevated chondrocyte apoptosis and catabolic activity play an important role. MicroRNA-155 (miR-155) has recently been shown to regulate apoptosis and catabolic activity in some pathological circumstances, yet, whether and how miR-155 is associated with OA pathology remain unexplored. We report here that miR-155 level is significantly up-regulated in human OA cartilage biopsies and also in primary chondrocytes stimulated by interleukin-1β (IL-1β), a pivotal pro-catabolic factor promoting cartilage degradation. Moreover, miR-155 inhibition attenuates and its overexpression promotes IL-1β-induced apoptosis and catabolic activity in chondrocytes in vitro. We also demonstrate that the PIK3R1 (p85α regulatory subunit of phosphoinositide 3-kinase (PI3K)) is a target of miR-155 in chondrocytes, and more importantly, PIK3R1 restoration abrogates miR-155 effects on chondrocyte apoptosis and catabolic activity. Mechanistically, PIK3R1 positively regulates the transduction of PI3K/Akt pathway, and a specific Akt inhibitor reverses miR-155 effects on promoting chondrocyte apoptosis and catabolic activity, phenocopying the results obtained via PIK3R1 knockdown, hence establishing that miR-155 promotes chondrocyte apoptosis and catabolic activity through targeting PIK3R1-mediated PI3K/Akt pathway activation. Altogether, our study discovers novel roles and mechanisms of miR-155 in regulating chondrocyte apoptosis and catabolic activity, providing an implication for therapeutically intervening cartilage degradation and OA progression.
BibTeX
@article{fan2020mir,
  author = {Zhiyong Fan and Yinghui Liu and Zhengliang Shi and Kai Deng and Hua Zhang and Qiutong Li and Shuxing Cao and Shentai Li and Hongliang Zhang and Hongliang Zhang and Hongliang Zhang},
  title = {{MiR‐155 promotes interleukin‐1β‐induced chondrocyte apoptosis and catabolic activity by targeting PIK3R1‐mediated PI3K/Akt pathway}},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2020},
  doi = {10.1111/jcmm.15388},
}
Figure